95 related articles for article (PubMed ID: 9256262)
1. Live HIV vaccines--how safe?
Dittmer U; Stahl-Hennig C; Hunsmann G
Nat Med; 1997 Aug; 3(8):816. PubMed ID: 9256262
[No Abstract] [Full Text] [Related]
2. Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine.
Desrosiers RC
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):331-2. PubMed ID: 8068412
[No Abstract] [Full Text] [Related]
3. AIDS vaccines. At conference, hope for success is further attenuated.
Cohen J
Science; 1994 Nov; 266(5188):1154. PubMed ID: 7973692
[No Abstract] [Full Text] [Related]
4. SIV vaccine for AIDS.
Farthing CF; Sullivan JL
Science; 1998 Jan; 279(5347):14-5. PubMed ID: 9441400
[No Abstract] [Full Text] [Related]
5. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
Baba TW; Jeong YS; Pennick D; Bronson R; Greene MF; Ruprecht RM
Science; 1995 Mar; 267(5205):1820-5. PubMed ID: 7892606
[TBL] [Abstract][Full Text] [Related]
6. Reconsidering an attenuated vaccine for AIDS.
Beale J
Lancet; 1996 Feb; 347(8998):344-5. PubMed ID: 8598696
[No Abstract] [Full Text] [Related]
7. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.
Daniel MD; Kirchhoff F; Czajak SC; Sehgal PK; Desrosiers RC
Science; 1992 Dec; 258(5090):1938-41. PubMed ID: 1470917
[TBL] [Abstract][Full Text] [Related]
8. Live attenuated AIDS vaccines: hazards and hopes.
Johnson RP
Nat Med; 1999 Feb; 5(2):154-5. PubMed ID: 9930861
[No Abstract] [Full Text] [Related]
9. Attenuated retrovirus vaccines and AIDS.
Shearer GM; Lucey DR; Clerici M
Science; 1995 Nov; 270(5239):1219; author reply 1220-2. PubMed ID: 7502053
[No Abstract] [Full Text] [Related]
10. Live-attenuated HIV vaccines: how safe is safe enough?
Murphey-Corb M
Nat Med; 1997 Jan; 3(1):17-8. PubMed ID: 8986728
[No Abstract] [Full Text] [Related]
11. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M
Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414
[TBL] [Abstract][Full Text] [Related]
12. Attenuated retrovirus vaccines and AIDS.
Van Rompay KK; Spinner A; Otsyula M; McChesney MB; Marthas ML
Science; 1995 Nov; 270(5239):1218-9; author reply 1220-2. PubMed ID: 7502051
[No Abstract] [Full Text] [Related]
13. Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge.
Gabriel B; Fiebig U; Hohn O; Plesker R; Coulibaly C; Cichutek K; Mühlebach MD; Bannert N; Kurth R; Norley S
Virology; 2016 Feb; 489():1-11. PubMed ID: 26685794
[TBL] [Abstract][Full Text] [Related]
14. AIDS doctors push for live-virus vaccine trials.
McCarthy M
Lancet; 1997 Oct; 350(9084):1082. PubMed ID: 10213561
[No Abstract] [Full Text] [Related]
15. Attenuated HIV vaccine: caveats.
Ruprecht RM; Baba TW; Liska V
Science; 1996 Mar; 271(5257):1790-2. PubMed ID: 8596941
[No Abstract] [Full Text] [Related]
16. "Attenuated" simian immunodeficiency virus in macaque neonates.
Ruprecht RM; Baba TW; Liska V; Bronson R; Penninck D; Greene MF
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):459-60. PubMed ID: 8882333
[No Abstract] [Full Text] [Related]
17. The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response.
Stahl-Hennig C; Steinman RM; Ten Haaft P; Uberla K; Stolte N; Saeland S; Tenner-Racz K; Racz P
J Virol; 2002 Jan; 76(2):688-96. PubMed ID: 11752159
[TBL] [Abstract][Full Text] [Related]
18. 1999: a time to re-evaluate AIDS vaccine strategies.
Ruprecht RM; Hofmann-Lehmann R; Rasmussen RA; Vlasak J; Xu W
J Hum Virol; 2000; 3(2):88-93. PubMed ID: 10850895
[TBL] [Abstract][Full Text] [Related]
19. HIV with multiple gene deletions as a live attenuated vaccine for AIDS.
Desrosiers RC
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1457. PubMed ID: 1466981
[No Abstract] [Full Text] [Related]
20. Infectivity and immunogenicity of SIVmac/HIV-1 chimeric viruses (SHIVs) with deletions in two or three genes (vpr, nef and vpx).
Igarashi T; Kuwata T; Yamamoto H; Moriyama H; Ui M; Miyazaki Y; Hayami M
Microbiol Immunol; 1998; 42(1):71-4. PubMed ID: 9525784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
